Engagement is part of I-Mab's commitment to transition to a U.S.-based biotech

PwC to serve as independent registered public accounting firm for FY 2024

ROCKVILLE, Md., Aug. 7, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) ("I-Mab", the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential...